Article Sidebar

Submitted
December 15, 2025
Published
May 1, 2026
Download
PDF
Statistic
Read Counter : 0 Download : 0

Main Article Content

Abstract

Chronic kidney disease (CKD) is a progressive condition characterized by a gradual decline in glomerular filtration rate, often accompanied by hypertension, necessitating antihypertensive therapy. This study aimed to evaluate the effectiveness of antihypertensive drugs in achieving blood pressure targets (<140/90 mmHg or a mean arterial pressure reduction of ≥20 mmHg) and to identify the incidence of adverse effects in CKD patients at Menggala Regional General Hospital during 2024. A retrospective observational study was conducted using medical records from 199 CKD inpatients selected via purposive sampling. Data analysis employed descriptive statistics, paired t-tests for effectiveness, and chi-square tests for associations between drug types. Results indicated that combination therapy with furosemide IV, candesartan, and amlodipine was the most common (77.4%) and demonstrated effectiveness in 50.8% of cases (p=0.01). Adverse effects occurred in only 1.0% of patients, primarily peripheral edema. The findings underscore the efficacy of combination therapies involving diuretics, ARBs, and CCBs in managing hypertension in CKD, with minimal adverse events. This research provides valuable insights for optimizing antihypertensive regimens in similar settings.

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

  1. Prasetya, N., Tanty, H. N., Iskandar, H., & Pranacistri, R. (2022). Gambaran penggunaan obat pada pasien penyakit ginjal kronik (PGK) yang menjalani hemodialisis di RS X Bekasi periode Januari–Maret 2020. Jurnal Riset Kefarmasian Indonesia, 4(2), 270–278. https://doi.org/10.33759/jrki.v4i2.269
  2. Arisandy, T., & Carolina, P. (2023). Hubungan dukungan keluarga dengan kualitas hidup pasien gagal ginjal kronik (GGK) yang menjalani terapi hemodialisa. Jurnal Surya Medika, 9(3), 32–35. https://doi.org/10.33084/jsm.v9i3.6463
  3. Ministry of Health (Kementerian Kesehatan Republik Indonesia). (2023). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/328/2023 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Penyakit Ginjal Kronik (Vol. 11, pp. 1–289).
  4. Ningsih, A. S., Inayati, A., & Hasanah, U. (2024). Penerapan aromaterapi inhalasi terhadap kecemasan pada pasien gagal ginjal kronik yang menjalani hemodialisa di ruang HD RSUD Jendral Ahmad Yani Kota Metro. Jurnal Cendikia Muda, 4(1), 43–52.
  5. Nisrina, A., Nurhayati, A., Pratiwi, A. R., & Akhriani, M. (2023). Hubungan risiko malnutrisi dengan persentase massa otot pada pasien penyakit ginjal kronik yang menjalani hemodialisa di RSUD Sukadana Kabupaten Lampung Timur tahun 2023. Jurnal Gizi Aisyah, 6(2), 157–165. https://doi.org/10.30604/jnf.v6i2.1407
  6. Pradiningsih, A., Nopitasari, B. L., Furqani, N., & Wahyuningsih, E. (2020). Evaluasi penggunaan obat antihipertensi pada pasien gagal ginjal kronik rawat inap di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 1(2), 1–13. https://doi.org/10.31764/lf.v1i2.2515
  7. Purwanti, E. (2024). Efektivitas Penggunaan Obat Antihipertensi pada Pasien Hipertensi dengan Gagal Ginjal Kronis di Rawat Inap RS PKU Muhammadiyah Gombong Tahun 2023 (Doctoral dissertation, Universitas Muhammadiyah Gombong).
  8. Husna, U. Y., Setyowati, E., Retnowati, E., Trinovitawati, Y., & Wahidah, N. (2024). Studi evaluasi efektivitas penggunaan antihipertensi terhadap tekanan darah pasien hemodialisa di RSI Sunan Kudus. IJF (Indonesia Jurnal Farmasi), 9(1), Article 2412. https://doi.org/10.26751/ijf.v9i1.2412
  9. James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., Lefevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Jr., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Jr., Narva, A. S., & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. https://doi.org/10.1001/jama.2013.284427
  10. Octariani, S., Mayasari, D., & Ramadhan, A. M. (2021, December). Proceeding of mulawarman pharmaceuticals conferences. In Proceeding Mulawarman Pharm. Conf (pp. 135-138).
  11. Sholihah, I., & Chalim, H. A. (2020). Kajian keamanan obat antihipertensi pada pasien penyakit ginjal kronik. Jurnal Ilmiah PANNMED (Pharmacist, Analyst, Nurse, Nutrition, Midwivery, Environment, Dentist), 15(3), 333–336. https://doi.org/10.36911/pannmed.v15i3.757
  12. Jayanti, M., Mpila, D., & Hariyanto, Y. A. (2024). Potensi efek samping obat antihipertensi di Puskesmas Kota Manado. Prosiding Seminar Nasional Kefarmasian Program Studi Farmasi FMIPA Universitas Sam Ratulangi, 2(1).
  13. Putri, S. A., Ramdini, D. A., Afriyani, A., & Wardhana, M. F. (2023). Efek samping penggunaan obat hipertensi [Literature review]. Jurnal Medula, 13(4), 583–589. https://doi.org/10.53082/medula.v13i4.1089
  14. Paranoan, R., Manggau, M. A., Kasim, H., Djide, M. N., Lallo, S., & Djabir, Y. Y. (2019). Analisis efektivitas dan efek samping penggunaan antihipertensi pada pasien gagal ginjal kronik rawat inap di RSUP Dr. Wahidin Sudirohusodo. Majalah Farmasi dan Farmakologi, 23(1), 13–15. https://doi.org/10.20956/mff.v23i1.6460
  15. Lestari, R. (2021). Evaluasi efektivitas antihipertensi pada pasien hipertensi dengan gagal ginjal kronis di rawat inap RSUD Kota Madiun (Bachelor Thesis, Sekolah Tinggi Ilmu Kesehatan Bina Husada Mandiri). http://repository.stikes-bhm.ac.id/id/eprint/1159
  16. Canoy, D., Nazarzadeh, M., Copland, E., Bidel, Z., Rao, S., Li, Y., & Rahimi, K. (2022). How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?. Current cardiology reports, 24(7), 851–860. https://doi.org/10.1007/s11886-022-01706-4
  17. Chang, P. Y., Chien, L. N., Lin, Y. F., Wu, M. S., Chiu, W. T., & Chiou, H. Y. (2016). Risk factors of gender for renal progression in patients with early chronic kidney disease. Medicine, 95(30), e4203. https://doi.org/10.1097/MD.0000000000004203
  18. Badariah, B., Kusuma, F. H. D., & Dewi, N. (2017). Karakteristik pasien penyakit ginjal kronik yang menjalani hemodialisis di RSUD Kabupaten Kotabaru. Nursing news, 2(2), 281–285. https://doi.org/10.33366/nn.v2i2.472
  19. Ariyani, H., Hilmawan, R. G., B. L. S., Nurdianti, R., Hidayat, R., & Puspitasari, P. (2019). Gambaran karakteristik pasien gagal ginjal kronis di unit hemodialisa Rumah Sakit Umum Dr. Soekardjo Kota Tasikmalaya. Keperawatan & kebidanan, 3(2), 1–6.
  20. Kurniawati, D. P., Khuluq, H., & Ainni, A. N. (2023). Faktor-faktor risiko yang mempengaruhi lama rawat inap pasien gagal ginjal kronik. Jurnal ‘Aisyiyah Medika, 8(2), 45–52. https://jurnal.stikes-aisyiyah-palembang.ac.id/index.php/JAM/article/view/1340
  21. Herawati, N., Saputri, G. A. R., & Yasir, A. S. (2021). Evaluasi rasionalitas penggunaan antihipertensi pada pasien geriatri di RSUD Dr. H Bob Bazar, SKM Lampung Selatan. Journal of islamic medicine, 5(2), 133–140. https://doi.org/10.18860/jim.v5i2.13435
  22. KDIGO Blood Pressure Work Group. (2021). KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International, 99(3, Suppl.), S1–S87. https://doi.org/10.1016/j.kint.2020.11.003
  23. Momuat, A. G. F., & Annisaa, E. (2023). Evaluasi rasionalitas penggunaan antihipertensi golongan angiotensin II receptor blocker (ARB) pada pasien penyakit ginjal kronis. Generics: Journal of Research in Pharmacy, 3(1), 55–64. https://doi.org/10.14710/genres.v3i1.17210
  24. Muhadi. (2016). JNC 8: Evidence-based guideline penanganan pasien hipertensi dewasa. Cermin Dunia Kedokteran, 43(1), 54–59.
  25. Maliza, F. N., Pratiwi, M., Safitri, A. A., & Purba, A. R. F. (2024). Efek samping obat pada pasien hipertensi. Jurnal Farmasi, 29(2), 29–33. https://doi.org/10.1234/abcd.5678
  26. Isnaini, R. D., Hasanatin, S., Dikdayani, L., & Apriliyani, F. (2022). Perbandingan efektivitas penurunan tekanan darah dengan pemberian kombinasi amlodipin dengan kaptopril dan amlodipin dengan lisinopril pada pasien hipertensi di Rumah Sakit PKU Muhammadiyah Mayong Jepara. Indonesia Jurnal Farmasi, 7(1), 78–86. https://jurnal2.umku.ac.id/index.php/IJF/article/view/1755
  27. Nuryanti, E., Wardhana, M. F., & Damayanti, E. (2024). Perbandingan efektivitas obat antihipertensi golongan ARB versus CCB terhadap penurunan tekanan darah pada pasien hipertensi. Medical Profession Journal of Lampung, 14(4), 712–718.
  28. Cho, M., Choi, C. Y., Choi, Y. J., & Rhie, S. J. (2023). Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis. Scientific reports, 13(1), 5727. https://doi.org/10.1038/s41598-023-32266-4
  29. Maritha, S., Ratnawati, R., & Dewi, O. (2021). Analisis parameter fungsi ginjal dan efektivitas antihipertensi pada pasien rawat inap hipertensi di RSUD Kota Madiun. Duta Pharma Journal, 1(1), 1-11. https://doi.org/10.47701/djp.v1i1.1187